Pharmabotic Nordic A/S: Financial statements 2025
CVR: 43526731
Source: annual report 2025, Danish Business Authority
01/10/2024 – 30/09/2025
Pharmabotic Nordic A/S (CVR 43526731) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 1,826,789 and a net result of DKK 1,393,542. Equity in the 2025 report amounted to DKK 1,477,912. The solvency ratio was 78.3%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 1,826,789
- Profit/Loss
- DKK 1,393,542
- Equity
- DKK 1,477,912
- Total Assets
- DKK 1,887,806
- Employees
- 1
Official annual report
How creditworthy is Pharmabotic Nordic A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of November 3, 2025, Steen Aage Bock has joined the board of directors of Pharmabotic Nordic A/S.
As of November 3, 2025, Clifford John Anthony has left the board of directors of Pharmabotic Nordic A/S.
Pharmabotic Nordic A/S has published its interim report for the period January 1, 2024 to September 30, 2024.
As of March 26, 2025, Beierholm Godkendt Revisionspartnerselskab has stepped down as auditor of Pharmabotic Nordic A/S.
About Pharmabotic Nordic A/S
Pharmabotic Nordic A/S is a Danish company of the type Aktieselskab based in Køge, founded in 2022. The company is registered under the industry Agenturhandel med specialiseret varesortiment, bortset fra køretøjer. The company was previously named Bico Tech A/S. The management consists of Peter Josephsen. The board consists of Anne Sofie Josephsen, Peter Josephsen and Steen Aage Bock. The company is owned by CAPS HOLDING ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 1,826,789 and a net result of DKK 1,393,542. Equity in the 2025 report amounted to DKK 1,477,912.
